文献速递头颈神经MR

采用合成MRI判断甲状腺相关眼病疾病活动性的初步研究

Pilot study using synthetic MRI for determining the disease activity of thyroid-associated ophthalmopathy.
PubMed 文献 · Br J Radiol · 2026-01-01

前瞻性纳入77例甲状腺相关眼病患者(活动期31例、非活动期46例),行眼眶合成MRI并生成定量图与对比加权图,计算眼外肌PD、T1、T2弛豫时间及信号强度比;活动期患者上述参数普遍高于非活动期,整合DIR-Mean、PD-Mean、T1RT-Mean、T2RT-Mean四者的联合模型诊断活动性的AUC为0.884,高于任一单独参数。

要点

  • 活动期甲状腺相关眼病眼外肌的PD、T1、T2定量值及多数对比加权图信号强度比高于非活动期。
  • DIR-Mean、PD-Mean、T1RT-Mean、T2RT-Mean为活动性的独立预测因子。
  • 四者联合模型诊断活动性的AUC 0.884,特异度89.13%、敏感度77.42%,优于各单独参数。

核心结论

  • 合成MRI可能成为判断甲状腺相关眼病疾病活动性的一种有前景的影像方法。

研究设计与样本

  • 前瞻性纳入77例甲状腺相关眼病患者(活动期31例、非活动期46例),行眼眶合成MRI并后处理生成T1图、T2图、质子密度图及DIR、STIR、FLAIR对比加权图。

关键影像表现/征象

  • 活动期患者眼外肌定量参数与半定量参数均高于非活动期患者,FLAIR-Min除外(均P < .05)。
  • 眼外肌DIR-Mean、PD-Mean、T1RT-Mean、T2RT-Mean与活动期甲状腺相关眼病独立相关(均P < .05)。

诊断标准与关键数值

  • 联合模型(整合4个独立预测因子)鉴别活动期与非活动期的AUC 0.884、特异度89.13%、敏感度77.42%。
  • 单独DIR-Mean的AUC为0.802,单独PD-Mean的AUC为0.818,单独T1RT-Mean的AUC为0.835,单独T2RT-Mean的AUC为0.824(均P < .05)。

临床应用与阅片要点

  • 合成MRI可在单次扫描、临床可接受的时间内定量眼外肌PD、T1RT与T2RT。
  • 本研究创新性地合成多幅对比加权图像,提高了甲状腺相关眼病分期的效能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the value of synthetic MRI (SyMRI) of extraocular muscles (EOMs) in determining the disease activity of thyroid-associated ophthalmopathy (TAO).

METHODS: Seventy-seven patients with TAO (31 active; 46 inactive) were prospectively enrolled. Orbital SyMRI was performed and post-processed to generate quantitative maps (T1 map, T2 map, and proton density [PD] map) and contrast-weighted images (double inversion recovery [DIR], short inversion recovery [STIR], and fluid-attenuated inversion recovery [FLAIR]). Maximum, mean, and minimum values of PD, T1 relaxation time (T1RT), and T2 relaxation time (T2RT) of EOMs, and the signal intensity ratio (SIR) of contrast-weighted images were calculated and compared between 2 groups. Multivariate logistic regression identified independent predictors of disease activity. Receiver operating characteristic curve analyses and DeLong tests evaluated and compared the diagnostic performance of significant parameters and combined models.

RESULTS: Active TAO patients had higher values of both quantitative and semi-quantitative parameters than inactive patients, except for FLAIR-Min (all P < .05). DIR-Mean, PD-Mean, T1RT-Mean, and T2RT-Mean of EOMs were independently associated with active TAO (all P < .05). The combined model integrating 4 independent predictors showed higher diagnostic performance (AUC, 0.884; specificity, 89.13%; sensitivity, 77.42%) than DIR-Mean (AUC = 0.802), PD-Mean (AUC = 0.818), T1RT-Mean (AUC = 0.835), or T2RT-Mean (AUC = 0.824) alone in distinguishing active from inactive patients (all P < .05).

CONCLUSIONS: SyMRI might be one promising imaging modality for determining the disease activity of TAO.

ADVANCES IN KNOWLEDGE: SyMRI quantifies PD, T1RT, and T2RT in a single scan with clinically acceptable time. Our study innovatively synthesized multiple contrast-weighted images, improving the efficacy of TAO staging.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Wan Y, Lu JL, Zhou J, et al. Pilot study using synthetic MRI for determining the disease activity of thyroid-associated ophthalmopathy. Br J Radiol. 2026. PMID: 41975131. doi:10.1093/bjr/tqag082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。